Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Ironwood Pharmaceuticals (IRWD) Work In Process (2016 - 2019)

Ironwood Pharmaceuticals' Work In Process history spans 2 years, with the latest figure at $392000.0 for Q4 2019.

On a quarterly basis, Work In Process changed N/A to $392000.0 in Q4 2019 year-over-year; TTM through Dec 2019 was $392000.0, a N/A change, with the full-year FY2019 number at $392000.0, changed N/A from a year prior.
Work In Process hit $392000.0 in Q4 2019 for Ironwood Pharmaceuticals, down from $707000.0 in the prior quarter.
Over the last five years, Work In Process for IRWD hit a ceiling of $707000.0 in Q3 2019 and a floor of $71000.0 in Q4 2016.